Real-World check on new lung cancer drug SHR-A1811
Disease control
Not yet recruiting
This study looks at how safe and effective the drug SHR-A1811 is for Chinese patients with advanced or spreading non-small cell lung cancer that has a specific change in the HER2 gene. About 1,000 adults will be followed as they receive the drug in regular medical practice. The g…
Sponsor: Nanjing Tianyinshan Hospital • Aim: Disease control
Last updated May 13, 2026 16:00 UTC